Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC)
Nefyn Williams(Betsi Cadwaladr University Health Board), Clare Wilkinson(Bangor University), David A. Walsh(Arthritis UK), Valerie Sparkes(Cardiff University), Alison Jenkins(Bangor University), Jaro Karppinen(University of Oulu), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Nia Goulden(Bangor University), Nadine E. Foster(Queensland Health), Dyfrig Hughes(Bangor University), Eifiona Wood(Bangor University), Dylan Morrissey(University of Miami), Stéphane Genevay(University of Geneva), Elaine M. Hay(Arthritis UK), Zoë Hoare(Bangor University), Dawn Carnes(University College of Osteopathy), Kika Konstantinou(Keele University)
Cited by 5
Related Papers
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Low back pain: a call for action
|The Lancet|2018|1.3k
Acupuncture for Chronic Pain
|Archives of Internal Medicine|2012|976